Composition BPC-157: 10 mg TB-500 (Thymosin Beta 4): 10 mg Appearance: lyophilized powder in a sealed research vial Research Focus (non-clinical) Combined evaluation of BPC-157 and TB-500 in in-vitro or ex-vivo assay systems Assay development, including chromatographic separation of two co-formulated peptides Stability characterization of a two-analyte lyophilized blend under laboratory storage conditions Documentation Lot-specific COA Batch and lot traceability Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability
Too little water: doses are stronger than intended This is the more concerning scenario
In laboratory research, administering 5-Amino-1MQ competitively inhibits NNMT activity, halting the clearance of nicotinamide
TB-500 promotes cellular migration and tissue remodeling by regulating actin polymerization and cytoskeletal organization, processes essential for regeneration and wound repair
Cell 185 , 24522468e16 (2022)
-Angiogenesis and Endothelial Protection The peptide promotes neovascularization by upregulating VEGFR2 and egr-1 pathways while stabilizing endothelial integrity under oxidative or inflammatory stress 1,2
